Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris

• Agnes S. Lo ,

  Contributed equally to this work with: Agnes S. Lo, Xuming Mao, Eric M. Mukherjee

  Affiliation Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Xuming Mao ,

  Contributed equally to this work with: Agnes S. Lo, Xuming Mao, Eric M. Mukherjee

  Affiliation Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Eric M. Mukherjee ,

  Contributed equally to this work with: Agnes S. Lo, Xuming Mao, Eric M. Mukherjee

  Affiliation Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Christoph T. Ellebrecht,

  Affiliation Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Xiaocong Yu,

  Affiliation Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Marshall R. Posner,

  Current address: The Tisch Cancer Institute, Mount Sinai School of Medicine, New York City, New York, United States of America

  Affiliation Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Aimee S. Payne ,

  ¶‡ These authors also contributed equally to this work.

  Affiliation Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Lisa A. Cavacini

  * E-mail: lisa.cavacini@umassmed.edu

  Current address: MassBiologics, 460 Walk Hill Street, Boston, Massachusetts, United States of America

  ¶‡ These authors also contributed equally to this work.

  Affiliation Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America

  http://orcid.org/0000-0003-1417-8339

  ⨯